Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
hsa-miR-936
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
GPR78
Cancer name
Laryngeal Squamous Cell Carcinoma
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Doxorubicin/Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Down
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78
Tissue resource
laryngeal squamous cell carcinoma and matching normal tissues
human laryngeal squamous cell carcinoma cell lines Hep-2
normal bronchial epithelium cell lines 16HBE
human embryonic kidney cell lines 293T
human laryngeal squamous cell carcinoma cell line KB-3-1
Experiment
None
Institute
the Third Affiliated Hospital, Sun Yat-sen University and the Department of Head and Neck, Cancer Center, Sun Yat-sen University
China Center for Type Culture Collection
St. John's University
Country
China
China
United States
Continent
Asia
Asia
North Amercian
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.